HER2-expressing cells are recognized by the HER2-specific CAR on FT825 T cells, triggering T-cell activation and cytolytic killing (perforin/granzyme and death receptor pathways); hnCD16 can also mediate ADCC if a compatible anti-HER2 antibody is present.